Byrne Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Other funds holding TMO
DLA
MSV
BTCPP
QPBE
FWCM
CIM
AIM
GA
AIM
AP
Byrne Asset Management's TMO Position: Q3 2026 in Review
Byrne Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 1.2% in Q3 2026, selling an estimated $2.97K and leaving 416 shares worth $271K. The position accounts for 0.15% of the portfolio, ranked #104.
Byrne Asset Management first reported a position in TMO in Q4 2021 and has held it in 18 quarters since. The position peaked at $822K in Q1 2022. 134 funds tracked by Wall St. Rank hold TMO as of Q3 2026.
- Byrne Asset Management held 416 shares of Thermo Fisher Scientific worth $271K as of Q3 2026.
- Byrne Asset Management sold 5 Thermo Fisher Scientific shares in Q3 2026, an estimated $2.97K.
- Thermo Fisher Scientific made up 0.15% of Byrne Asset Management's portfolio in Q3 2026, its #104 holding.
- Byrne Asset Management first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 18 quarters since.
- Byrne Asset Management's Thermo Fisher Scientific position peaked at $822K in Q1 2022.
- 134 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.
Based on Byrne Asset Management's 13F filing for Q3 2026, filed 6 Oct 2026.